VERU
VERU
NASDAQ · Pharmaceuticals

Veru Inc

$2.48
+0.07 (+2.90%)
As of Sep 21, 5:16 PM ET ·
Financial Highlights (FY 2026)
Revenue
20.73M
Net Income
-46,398,927
Gross Margin
34.7%
Profit Margin
-223.9%
Rev Growth
-34.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.7% 34.7% 54.7% 54.7%
Operating Margin -218.6% -196.7% 29.3% 32.3%
Profit Margin -223.9% -212.7% 24.9% 21.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 20.73M 31.85M 6.59M 7.88M
Gross Profit 7.19M 11.04M 3.61M 4.31M
Operating Income -45,311,211 -62,661,478 1.93M 2.55M
Net Income -46,398,927 -64,165,694 1.64M 1.71M
Gross Margin 34.7% 34.7% 54.7% 54.7%
Operating Margin -218.6% -196.7% 29.3% 32.3%
Profit Margin -223.9% -212.7% 24.9% 21.7%
Rev Growth -34.9% -34.9% +19.2% -4.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 6.76M 7.86M
Total Equity 15.00M 16.14M
D/E Ratio 0.45 0.49
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -44,981,812 -65,661,833 3.19M 3.50M
Free Cash Flow 1.30M 1.17M